Rituximab or cyclophosphamide in ANCA-associated renal vasculitis

N Engl J Med. 2010 Nov 18;363(21):2072; author reply 2073-4. doi: 10.1056/NEJMc1009101.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / drug therapy*
  • Antibodies, Monoclonal, Murine-Derived / therapeutic use*
  • Cyclophosphamide / therapeutic use*
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Diseases / drug therapy*
  • Remission Induction
  • Rituximab
  • Treatment Failure

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Immunosuppressive Agents
  • Rituximab
  • Cyclophosphamide